<DOC>
	<DOCNO>NCT01118936</DOCNO>
	<brief_summary>The present study part project title 'Magnesium asthma chronic obstructive pulmonary disease ' . The hypothesis main project daily magnesium supplement benefit patient asthma chronic obstructive pulmonary disease . The aim part project study effect daily magnesium supplement COPD-patients</brief_summary>
	<brief_title>Daily Magnesium-treatment Patients With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Magnesium Hydroxide</mesh_term>
	<criteria>COPDpatients , grade moderatesevere ( FEV1 3080 % expect . FEV1/FVC &lt; 0,7 ) . SeMg &gt; 2,00 mmol/L , smoke cessation le 1 year prior study start , submission hospital within last two year , submission hospital exacerbation study period , major change eat habit within three month prior study start study period approx.one year various condition ( e.g . gastrointestinal disease , kidney disease , pregnancy/lactation ) may affect study result .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>Daily magnesium supplement</keyword>
	<keyword>EQ-5D</keyword>
</DOC>